Related Experiment Videos
Tetramethylpyrazine protects mice against thioacetamide-induced acute hepatotoxicity
Edmund C So1, Kar-Lok Wong, Tian-Chyuan Huang
1Department of Anesthesiology, Chi-Mei Medical Center, Tainan, Taiwan, ROC.
Abstract:
In this study, the intraperitoneal administration of 1 mg/kg thioacetamide (TAA) produced hepatotoxicity in mice. The increase in serum SGOT and SGPT produced at 24 h by this regimen was decreased in a dose-dependent manner by coadministration of tetramethylpyrazine (TMP; 10, 25 and 50 mg/kg). A rise in serum interleukin-2 was similarly prevented. Increased concentrations of malondialdehyde (MDA) generated in vitro in liver homogenates prepared from TAA-treated mice were decreased by TMP treatments. The increase in MDA produced by TAA was also prevented by in vitro addition of TMP to liver homogenates. These results suggest that part of the hepatocellular injury induced by TAA is mediated by oxidative stress caused by the action of cytokines through lipid peroxidation. TMP appears to act by preventing lipid peroxidation.
Insights
Tetramethylpyrazine (TMP) protects against thioacetamide-induced liver injury in mice by reducing oxidative stress and lipid peroxidation. This compound effectively lowers liver enzymes and malondialdehyde levels, indicating a protective effect against hepatotoxicity.
Area of Science:
- Biochemistry
- Toxicology
- Pharmacology
Background:
- Thioacetamide (TAA) is a known inducer of hepatotoxicity in experimental models.
- Oxidative stress and lipid peroxidation are implicated in TAA-induced liver injury.
- Cytokines play a role in mediating hepatocellular damage.
Purpose of the Study:
- To investigate the protective effects of tetramethylpyrazine (TMP) against TAA-induced hepatotoxicity.
- To elucidate the mechanism underlying TMP's protective action, focusing on oxidative stress and lipid peroxidation.
Main Methods:
- Hepatotoxicity was induced in mice via intraperitoneal administration of thioacetamide (TAA).
- Coadministration of varying doses of tetramethylpyrazine (TMP) was employed.
- Serum levels of liver enzymes (SGOT, SGPT), interleukin-2, and malondialdehyde (MDA) were measured.
- In vitro experiments assessed the effect of TMP on MDA generation in liver homogenates.
Main Results:
- TAA administration significantly increased serum SGOT, SGPT, and interleukin-2 levels.
- TMP treatment dose-dependently decreased these elevated serum markers.
- Increased malondialdehyde (MDA) concentrations in TAA-treated mice were reduced by TMP.
- TMP inhibited MDA generation both in vivo and in vitro, suggesting prevention of lipid peroxidation.
Conclusions:
- Tetramethylpyrazine (TMP) exhibits significant hepatoprotective effects against thioacetamide (TAA)-induced liver injury.
- TMP's mechanism of action involves the mitigation of oxidative stress and the inhibition of lipid peroxidation.
- These findings highlight TMP as a potential therapeutic agent for conditions involving TAA-induced hepatotoxicity.